Are You Looking For Medical Devices Certifications?
Contact UsConnect With Us
A Clinical Evaluation Report (CER) is a vital document for obtaining CE marking in Europe, serving to assess the safety and performance of a medical device by compiling clinical data from various sources. This data, essential for compliance, can be gathered through literature reviews, clinical investigation studies, post-market surveillance data, and information from equivalent devices already on the market. CER writing demands in-depth knowledge of the product, including its mechanism of action, attributes, scientific validity, associated risks, adverse events, precautions, and contraindications. For an effective CER, often guided by MDCG clinical evaluation guidelines, manufacturers may refer to a clinical evaluation report example for insights. CER development typically begins in the design and development phase and requires a qualified evaluator, whose hiring must be justified as per MEDDEV Section 6 requirements.
A Clinical Evaluation Report involves four main steps:
A well-prepared Clinical Evaluation Report (CER) is crucial for meeting regulatory compliance under the MDR CER requirements. By incorporating the necessary elements and following the outlined steps, manufacturers can effectively demonstrate the safety and efficacy of their medical devices. Utilizing a clinical evaluation report template simplifies the process, ensuring accuracy and completeness. For better understanding, reviewing a clinical evaluation report sample can provide valuable insights into structuring and presenting your CER effectively.
In accordance with MDR regulations, it is essential to maintain up-to-date Post-Market Surveillance (PMS) or Post-Market Clinical Follow-up (PMCF) data to ensure the continued safety and effectiveness of your medical device. PMCF is a continuous process that involves actively collecting and analyzing clinical data from a device already CE marked. This data helps in updating the clinical evaluation and supports the ongoing assessment of the device’s performance. For guidance, a clinical evaluation report example can be used to understand the necessary structure, while the clinical evaluation report format ensures consistency in presenting the collected data.
Updates to the CER may be necessary if any new Post-Market Surveillance (PMS) or PMCF data is discovered that could impact the current evaluation or its conclusions. This includes making sure the medical device CER reflects the latest clinical data and findings.
You can download the updated MEDDEV 2.7/1 Rev 4 updated in June 2016 guidelines, which offer comprehensive instructions on conducting a clinical evaluation for medical device manufacturers. These guidelines are essential for ensuring compliance with directives 93/42/EEC and 90/385/EEC. Following the MDCG clinical evaluation framework will help manufacturers meet regulatory requirements, supporting the successful certification of their medical devices.
The structure of a Clinical Evaluation Report (CER) for medical devices is pivotal in ensuring regulatory compliance and demonstrating the safety and performance of the device. A well-structured CER medical device should begin with essential details such as the device name, manufacturer, and intended purpose. It should then provide a comprehensive review of the clinical data, including scientific literature, clinical investigations, and Post-Market Surveillance (PMS) data. The CER must also include an analysis of the benefit-risk ratio, drawing conclusions on the device’s overall safety and effectiveness. The report should conclude with the qualifications of the evaluator and any necessary evidence supporting the device’s compliance with General Safety and Performance Requirements (GSPR). A structured and comprehensive clinical evaluation report for medical devices plays a critical role in obtaining CE marking and ensuring market readiness.
Clinical evidence plays a crucial role in the Clinical Evaluation Report (CER) process for medical devices, ensuring they meet safety and performance standards under the EU MDR. The evidence must be gathered from reliable sources, such as clinical investigations, Post-Market Surveillance (PMS), and Post-Market Clinical Follow-up (PMCF) data. The evaluation of this clinical data is necessary to establish a medical device’s compliance with the General Safety and Performance Requirements (GSPR). To meet MDR clinical evaluation standards, manufacturers must ensure their CER incorporates comprehensive, high-quality evidence that supports the device’s safety, efficacy, and intended use. Effective clinical evidence analysis contributes significantly to successful CE marking.
Once a Clinical Evaluation Report (CER) is completed, it undergoes a thorough review to ensure that all required data and assessments align with regulatory requirements, particularly the EU MDR standards. After completion, the CER is submitted as part of the technical documentation for CE marking, supporting the device’s safety and efficacy claims. If new clinical data becomes available, the CER may require updates to reflect ongoing Post-Market Surveillance (PMS) or Post-Market Clinical Follow-up (PMCF) findings. The MDCG clinical evaluation report guidelines offer essential instructions for maintaining the CER’s accuracy and compliance throughout the device’s lifecycle. Continuous monitoring ensures that the Clinical Evaluation Report CER remains valid as long as the product is on the market.
For more information please watch this video
Looking for a template to guide you prepare your Clinical Evaluation Reports (CER) in-house? Buy once and use it for multiple product CER writing. These Clinical Evaluation Report (CER) templates are in compliance with MEDDEV 2.7/1 Rev 4, EU MDR, applicable MDCG guidelines.
Clinical evaluation a methodologically sound ongoing procedure to collect, appraise and analyse clinical data pertaining to a medical device and to evaluate whether there is sufficient clinical evidence to confirm compliance with relevant general safety and performance requirements for safety and performance when using the device according to the manufacturer’s Instructions for Use.
It has been mentioned clearly in section 6.4 of MEDDEV guideline for clinical evaluation that manufacturer should consider certain aspects in selecting the evaluators and justifying the same.
Certain aspects need to be considered while selecting a evaluator are:
Yes, clinical evaluation is an ongoing process and conducted throughout the life cycle of a medical device. Clinical evaluation is mandatory for initial CE-marking and it must be actively updated thereafter.
There guidelines/standards that must be observed when creating a clinical evaluation, such as the MEDDEV 2.7/1 Rev. 4 (2016), MDCG 2020-5 and 2020-6 or requirements & from the ISO 14155.
Clinical investigation is systematic investigation in one or more human subjects, to assess the safety or performance of a medical device and Clinical evaluation of medical devices is a systematic and planned process that contributes to the continuous generation, collection, analysis and evaluation of clinical data on a particular device.
Clinical evaluation needs to be actively updated and manufacturer need to define and justify the frequency. While deciding the frequency, manufacturer should consider whether a medical device carries a significant risks, design changes or any changes in manufacturing procedures, new information from PMS that has importance to change the current clinical evaluation.
If there is no such information is received, it has to be updated